MFN2 and acute myeloid leukemia: Loss of MFN2 disrupts mitochondrial-ER associated membranes (MAMs) in AML cells, hence impairing autophagosome formation, lipid catabolism, FAO, and OXPHOS, while also preventing the elimination of defective mitochondria through mitophagy [127, 132].